Folik Asit
Synopsis
Folik asit, vücutta karbon metabolizması için önemli olan bir bileşen olarak bilinir. Bu nedenle, kanserle ilişkisi üzerine yapılan araştırmalar, folik asidin karsinogenez üzerindeki potansiyel etkilerini ayrıntılı bir şekilde incelemiştir. 5-Metiltetrahidrofolat (5-MTHF) olarak bilinen bir folat türü ile kobalamin, metiyonin yolu üzerinde gereklidir; bu yol, homosisteinin metiyonine dönüştürülmesinde önemli bir rol oynar. Metiyonin, S-adenozilmetiyonine (SAM) dönüşür ve bu, vücuttaki birçok reaksiyonda metil kaynağı olarak işlev görür, özellikle DNA ve RNA metilasyonunda. SAM'nin yetersiz üretimi, DNA'daki metilasyonun azalmasına ve gen transkripsiyonunu etkileyerek tümör baskılayıcı genlerin ve proto-onkogenlerin ifadesini değiştirebilir. Folat eksikliği, DNA sentezi ve onarımı için gereken nükleik asit olan deoksiribonükleotid monofosfatın dönüşümünü engelleyebilir. Bu durum, hatalı DNA sentezi ve onarımına, DNA zincir kırıklarına ve hatalı DNA onarımına yol açabilir. Kanser, genomdaki birikmiş mutasyonlarla gelişen sistemik bir hastalıktır. Folatın kanser riski ile ilişkisi, bilinen biyokimyasal mekanizmalarla daha da güçlenir. Folat varlığı, normal dokularda kanserin gelişimini ve ilerlemesini düzenleyebilir. Birçok çalışma, folat alımı veya düzeyi ile kolorektal, meme, servikal, pankreas, beyin ve akciğer kanserleri gibi birçok kanser türü arasında bir ilişki gözlemlemiştir. Folat düzeyi ve kanser arasındaki ilişki tam olarak netleşmemiş olsa da, bilimsel çalışmalar bu konuya ilgi göstermektedir. Folik asidin kanseri önleme veya destekleme potansiyeline dair çelişkili bulgular vardır. Folik asit takviyesi, premalign lezyon olmayan ve folat eksikliği olan bireylerde koruyucu olabilir, ancak yüksek dozlarda alınması premalign lezyonların ilerlemesine yol açabilir. Aşırı folat alımı da endişe yaratmaktadır. Nöral tüp defektlerinin insidansını azaltmayı amaçlayan buğday unu ve zenginleştirilmiş tahıl ürünleri ile gerçekleştirilen zorunlu güçlendirme programı, kanser insidansında artış ve premalign lezyonların ilerlemesi endişesi yaratmıştır. Folik asidin kanser riski üzerinde karmaşık etkileri bulunmaktadır; bazı kanser türleri için koruyucu olabilirken diğerleri için etkili olmayabilir veya riski artırabilir. Genetik polimorfizmler, folat metabolizması üzerinde etkili olabilir ve bazı etnik gruplarda kanser riskini artırabilir. Bu nedenle, klinisyenler folat alımını bireyselleştirerek, örneğin alkol bağımlılığı veya malabsorpsiyonu olan bireylerde alımı takviye etmeye yönelik olarak hareket etmelidir. Folik asit, nöral tüp defektleri riskini azaltabilir. Gebelik öncesinde folik asit takviyesine başlamanın, nöral tüp defektlerini önlemede etkili olduğu gösterilmiştir. Ancak, bu takviyenin herkes tarafından yeterince alınıp alınmadığına dair endişeler bulunmaktadır.
Folic acid plays a critical role in one-carbon metabolism and has been extensively studied regarding its potential implications in carcinogenesis. Its involvement in DNA methylation and nucleic acid synthesis affects gene expression and influences the balance between tumor-suppressing genes and proto-oncogenes. While folate deficiency hinders DNA synthesis and repair, excessive intake might lead to erroneous DNA incorporation and faulty repair mechanisms, culminating in unstable DNA and increased cancer risk. The relationship between folate levels and cancer is complex. Studies indicate a dual role, where adequate levels can prevent cancer in healthy individuals while potentially aiding the progression of premalignant or malignant lesions. High-dose folic acid supplementation may exacerbate premalignant lesions' advancement, highlighting a fine line between cancer prevention and support. Serum folate inadequacy has been linked to increased risks in various cancers, while excessive intake, particularly above physiological levels, could potentially promote cancer progression. The interaction between folate intake and cancer varies across different cancer types, showing protective effects for some and increased risk potential for others. Genetic polymorphisms in enzymes involved in folate metabolism further complicate this relationship, influencing DNA methylation and potentially impacting disease risk. Studies on the correlation between folate and cancer risk often present mixed or inconclusive findings, necessitating further research to ascertain precise effects and recommendations for specific populations. Moreover, the association between folic acid and neural tube defects (NTDs) underscores its role in embryonic development. Folic acid supplementation has been shown to significantly reduce the recurrence risk of NTDs, prompting recommendations for its preconception use to prevent congenital anomalies. However, concerns persist regarding potential adverse effects, including the masking of vitamin B12 deficiency, epigenetic alterations in cancer, and the presence of unmetabolized folic acid in circulation. While ongoing research continues to explore these complexities, monitoring and further investigation are imperative for a comprehensive understanding of folic acid's implications in health and disease.
References
“Folic acid: nutritional biochemistry, molecular biology, and role in disease processes”, Molecular genetics and metabolism, 71(1-2), 121–138.
Sanderson, P.; McNulty, H.; Mastroiacovo, P.; McDowell, I.F.W.; Melse-Boonstra, A.; Finglas, P.M.; Gregory, J.F., III. Folate bioavailability: UK food standards agency workshop report. Br. J. Nutr. 2003, 90, 473–479. [CrossRef] [PubMed
Powers, H.J. Folic acid under scrutiny. Br. J. Nutr. 2007, 98, 665–666. [CrossRef] [PubMed]
Bailey, S.W.; Ayling, J.E. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc. Natl. Acad. Sci. USA 2009, 106, 15424–15429. [CrossRef] [PubMed
Rosenquist, Thomas H. "Folate, homocysteine and the cardiac neural crest." Developmental Dynamics 242.3 (2013): 201-218.
Yüksekdağ, Z. N., Zeydanlı, M. N. (2014). “Folat Eksikliği ve Probiyotikler”. Nevşehir Bilim ve Teknoloji Dergisi, 2(2): 21-36.
Shane, B. Folate chemistry and metabolism. In Folate in Health and Disease; Bailey, L.B., Ed.; CRC Press: New York, NY, USA, 2010; pp. 2–3.
Keser, N., Pazarbaşı, A., Özpak, L. (2014). “Metilentetrahidrofolat Redüktaz Aktivitesi ve Folat Metabolizması”. Arşiv Kaynak Tarama Dergisi, 23(2): 237-256.
Dayı, T., Pekcan, G. (2019). “Gebelerde Folik Asit Desteği Ve Güncel Yaklaşımlar”. Food And Health, 5(2): 128-138.
Gropper SS, Smith JL. Advanced nutrition and human metabolism, 6th Edition [Internet]. Wadsworth Belmont, CA; 2013. p. 344–353. Available from: https://www.cengage.co.uk/ books/9781133104056/
Health NI of Folate. Dietary Supplement Fact Sheet. [Internet]. National Institutes of Health. 2012 [cited 2018 Jun 6]. p. 1–10. Available from: https://ods.od.nih.gov/factsheets/Folate- HealthProfessional/#en2
Crider KS, Bailey LB, Berry RJ. Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients. 2011;3(3):370–84.
Avşar, A., Kaya, S., Kaya, B. (2012). “Türkiye’de Folik Asit Perikonsepsiyonel Olarak Kullanılmalı Mıdır? ”. Ankara Medical Journal, 12(4): 188-194.
Güran, Ş., Çoban, Z. D. (2012). “Nöral Tüp Defektinde Etkilenen Mekanizmalar, Hastalığın Moleküler Biyolojisi ve Genetiği”. Türkiye Klinikleri Journal of Pediatrics, 21(4): 224-229.
Bortolus, R., Blom, F., Filippini, F., Van Poppel, M. N., Leoncini, E., de Smit, D. J., Mastroiacovo, P. (2014). “Prevention Of Congenital Malformations And Other Adverse Pregnancy Outcomes With 4.0 mg Of Folic Acid: Community-Based Randomized Clinical Trial in Italy And The Netherlands”. BMC pregnancy and childbirth, 14(1): 166
Kabaran, S., Ayaz, A. (2013). “Maternal ve Fetal Sağlık Üzerinde B12, Folik Asit, A, D, E ve C Vitaminlerinin Etkileri”. Türk Hijyen ve Deneysel Biyoloji Dergisi, 70(2): 103-112.
Rai V. Folate pathway gene MTHFR C677T polymorphism and risk of lung cancer in Asian populations. Asian Pacific J Cancer Prev. 2014;15(21):9259–64.
Blagosklonny, M. V. (2005). “Molecular Theory Of Cancer”. Cancer Biology & Therapy, 4(6): 621-627.
Kim, Y. I. (2004). “Will Mandatory Folic Acid Fortification Prevent Or Promote Cancer?”. The American Journal Of Clinical Nutrition, 80(5): 1123-1128.
McNulty, H., Scott, J. M. (2008). “Intake And Status Of Folate And Related B-Vitamins: Considerations and Challenges In Achieving Optimal Status”. British Journal of Nutrition, 99(3): 48-54.
Kabaran, S., Ayaz, A. (2013). “Maternal ve Fetal Sağlık Üzerinde B12, Folik Asit, A, D, E ve C Vitaminlerinin Etkileri”. Türk Hijyen ve Deneysel Biyoloji Dergisi, 70(2): 103-112.
BALKİS, Beyzanur, et al. "Folik Asitin Kanser Hücreleri Üzerine Etkisi ve Sitotoksisitelerinin Değerlendirilmesi." Bilim Armonisi 5.2 (2023): 24-31.
Keser, N., Pazarbaşı, A., Özpak, L. (2014). “Metilentetrahidrofolat Redüktaz Aktivitesi ve Folat Metabolizması”. Arşiv Kaynak Tarama Dergisi, 23(2): 237-256.
Gruber B. B-group vitamins: chemoprevention? Adv Clin Exp Med [Internet]. 2016;25(3):561–8. Available from: http://www. advances.umed.wroc.pl/en/article/2016/25/3/561/. Review on the role of B vitamins in chemoprevention.
Pieroth, R., Paver, S., Day, S., Lammersfeld, C. (2018). “Folate And Its Impact On Cancer Risk”. Current Nutrition Reports, 7(3): 70-84.
Kim, Y. I. (2003). “Role Of Folate In Colon Cancer Development And Progression”. The Journal Of Nutrition, 133(11): 3731-3739.
Fan C, Yu S, Zhang S, Ding X, Su J, Cheng Z. Association between folate intake and risk of head and neck squamous cell carcinoma. Medicine (Baltimore) [Internet]. 2017;96(42): e8182. Available from: http://insights.ovid.com/crossref?an= 00005792-201710200-00039
Galeone C, Edefonti V, ParpinelM, Leoncini E, Talamini R, Olshan AF, et al. Folate intake and the risk of oral cavity and pharyngeal cancer: a pooled analysis within the INHANCE Consortium Carlotta. 2016;136(4):904–14
TioM, Andrici J, Cox MR, Eslick GD. Folate intake and the risk of upper gastrointestinal cancers: a systematic review and meta-analysis. J Gastroenterol Hepatol [Internet]. 2014;29(2):250–8. https:// doi.org/10.1111/jgh.12446
Lin HL, An QZ, Wang QZ, Liu CX. Folate intake and pancreatic cancer risk: an overall and dose-response meta-analysis. Public Health. 2013;127(7):607–13
He H, Shui B. Folate intake and risk of bladder cancer: a metaanalysis of epidemiological studies. Int J Food Sci Nutr. 2014;65(3):286–92.
Pakdemirli, A., Toksöz, F. (2019). “Folik Asidin Endotel Hücrelerinde Proliferasyon Üzerine Etkisi”. Tepecik Eğitim. ve Araştırma Hastanesi Dergisi, 29(1): 86-90
Kotsopoulos, J., Kim, Y. I., Narod, S. A. (2012). “Folate And Breast Cancer: What About High-Risk Women?”. Cancer Causes & Control, 23(9): 1405-1420.
Varela-Rey M, Woodhoo A, Martinez-Chantar ML, Mato JM, Lu SC. Alcohol, DNA methylation, and cancer. Alcohol Res: Curr Rev. 2013;35(1):25–35.
Zhang D, Wen X, Wu W, Guo Y, Cui W. Elevated homocysteine level and folate deficiency associated with increased overall risk of carcinogenesis: meta-analysis of 83 case-control studies involving 35,758 individuals. PLoS One. 2015;10(5):1–16.
Rai V. The methylenetetrahydrofolate reductase C677T polymorphism and breast cancer risk in asian populations. Asian Pacific J Cancer Prev. 2014;15(14):5853–60.
Bistulfi G, Vandette E, Matsui S-I, Smiraglia DJ. Mild folate deficiency induces genetic and epigenetic instability and phenotype changes in prostate cancer cells. BMC Biol. 2010;8:6.
Marini NJ, Gin J, Ziegle J, Keho KH, Ginzinger D, Gilbert DA, et al. The prevalence of folate-remedial MTHFR enzyme variants in humans. Proc Natl Acad Sci U S A. 2008 Jun;105(23):8055–60.
Miller, J. W., Ulrich, C. M. (2013). “Folic Acid And Cancer—Where Are We Today?”. The Lancet, 381(9871): 974-976.
Pieroth, Renee, et al. "Folate and its impact on cancer risk." Current nutrition reports 7 (2018): 70-84.
Hibbard, B.M.; Hibbard, E.D.; Jeffcoate, T.N. Folic acid and reproduction. Acta Obstet. Gynecol. Scand. 1965, 44, 375–400.
Smithells, R.; Nevin, N.; Seller, M.; Sheppard, S.; Harris, R.; Read, A.; Fielding, D.; Walker, S.; Schorah, C.; Wild, J. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1983, 1, 1027–1031.
Mulinare, J.; Cordero, J.F.; Erickson, J.D.; Berry, R.J. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988, 260, 3141–3145.
Bower, C.; Stanley, F.J. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med. J. Aust. 1989, 150, 613–619.
MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991, 338, 131–137.
Czeizel, A.E.; Dudas, I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 1992, 327, 1832–1835.
Centers for Disease Control and Prevention. Use of folic acid for prevention of spina bifida and other neural tube defects—1983–1991. MMWR Morb. Mortal. Wkly. Rep. 1991, 40, 513–516.
Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm. Rep. 1992, 41, 1–7.
Institute of Medicine. Folate. In Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline; National Academy Press: Washington, DC, USA, 1998; pp. 196–305.
U.S. Preventive Services Task Force. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 2009, 150, 626–631.
Ray, J.G.; Singh, G.; Burrows, R.F. Evidence for suboptimal use of periconceptional folic acid supplements globally. BJOG 2004, 111, 399–408.
Quinlivan, E.P.; Gregory, J.F., III. Reassessing folic acid consumption patterns in the United States (1999–2004): potential effect on neural tube defects and overexposure to folate. Am. J. Clin. Nutr. 2007, 86, 1773–1779.
Yang, Q.H.; Carter, H.K.; Mulinare, J.; Berry, R.J.; Friedman, J.M.; Erickson, J.D. Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001–2002. Am. J. Clin. Nutr. 2007, 85, 1409–1416.
Rader, J.I.; Weaver, C.M.; Angyal, G. Total folate in enriched cereal-grain products in the United States following fortification. Food Chem. 2000, 70, 275–289.
Berner, L.A.; Clydesdale, F.M.; Douglass, J.S. Fortification contributed greatly to vitamin and mineral intakes in the United States, 1989–1991. J. Nutr. 2001, 131, 2177–2183.
Imhoff-Kunsch, B.; Flores, R.; Dary, O.; Martorell, R. Wheat flour fortification is unlikely to benefit the neediest in Guatemala. J. Nutr. 2007, 137, 1017–1022.
Centers for Disease Control and Prevention. CDC Grand Rounds: Additional Opportunities to Prevent Neural Tube Defects with Folic Acid Fortification. MMWR Morb. Mortal. Wkly. Rep. 2010, 59, 980–984.
Berry, R.J.; Mulinare, J.; Hamner, H.C. Folic acid fortification: neural tube defect risk reduction—a global perspective. In Folate in Health and Disease, 2nd ed.; Bailey, L.B., Ed.; CRC Press: Boca Raton, FL, USA, 2010; pp. 179–204.
Molloy, A.M.; Kirke, P.N.; Troendle, J.F.; Burke, H.; Sutton, M.; Brody, L.C.; Scott, J.M.; Mills, J.L. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic Acid fortification. Pediatrics 2009, 123, 917–923
Institute of Medicine. Folate. In Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline; National Academy Press: Washington, DC, USA, 1998; pp. 196–305.
Ciappio, E.; Mason, J.B. Folate and carcinogenesis basic mechanisms. In Folate in Health and Disease, 2nd ed.; Bailey, L.B., Eds.; CRC Press, Taylor & Francis Group: Boca Raton, FL, USA, 2009; pp. 235–262.
Bailey, L. Folic Acid. Handbook of Vitamins; CRC Press, Taylor & Francis Group: Boca Raton, FL, USA, 2007.
Sweeney, M.; McPartlin, J.; Scott, J. Folic acid fortification and public health: Report on threshold doses above which unmetabolised folic acid appear in serum. BMC Public Health 2007, 7, 41.
Bailey, R.L.; Mills, J.L.; Yetley, E.A.; Gahche, J.J.; Pfeiffer, C.M.; Dwyer, J.T.; Dodd, K.W.; Sempos, C.T.; Betz, J.M.; Picciano, M.F. Unmetabolized serum folic acid and its relation to folic acid intake from diet and supplements in a nationally representative sample of adults aged ≥60 y in the United States. Am. J. Clin. Nutr. 2010, 92, 383–389.
Morris, M.S.; Jacques, P.F.; Rosenberg, I.H.; Selhub, J. Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. Am. J. Clin. Nutr. 2010, 91, 1733–1744.
TANRIVERDİ, Esra ÇINAR. "Zülal ÖZKURT." Turkiye Klinikleri J Inf Dis-Special Topics 10.1 (2017): 71-4.
Çelik, Abdullah. Bis-antranilesterlerden sülfonamid sentezi. MS thesis. Trakya Üniversitesi Fen Bilimleri Enstitüsü, 2015.
